Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline in Pseudohypoparathyroidism
NCT03718403Phase 4Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2019
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of theophylline in pseudohypoparathyroidism (PHP), sponsored by Massachusetts General Hospital. Started Nov 2019; status: recruiting.
02
Drugs
theophylline
03
Conditions
pseudohypoparathyroidism (PHP)
Beyond the preview
Go deeper on NCT03718403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03718403.